Insider Trading & Ownership - FRATES JAMES M

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for FRATES JAMES M
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-09-12
Purchase
2024-09-16
5:30 pm
Amylyx Pharmaceuticals Inc.AMLXFRATES JAMES M
Chief Financial Officer
40,000$2.5342$101,368259,995
(Indirect
Direct)
View
2024-03-05
Sale
2024-03-07
4:05 pm
Amylyx Pharmaceuticals Inc.AMLXFRATES JAMES M
Chief Financial Officer
1,792$18.73$33,560161,315
(Indirect
Direct)
View
2024-01-09
Sale
2024-01-11
5:11 pm
Amylyx Pharmaceuticals Inc.AMLXFRATES JAMES M
Chief Financial Officer
2,716$16.33$44,347123,107
(Indirect
Direct)
View
2023-05-16
Sale
2023-05-18
8:54 pm
Amylyx Pharmaceuticals Inc.AMLXFRATES JAMES M
Chief Financial Officer
32,500$26.94$875,451457,158
(Indirect
Direct)
View
2023-03-16
Sale(A)
2023-03-24
6:48 pm
Amylyx Pharmaceuticals Inc.AMLXFRATES JAMES M
Chief Financial Officer
32,500$31.89$1,036,459567,676
(Direct)
View
2023-03-16
Sale
2023-03-20
8:18 pm
Amylyx Pharmaceuticals Inc.AMLXFRATES JAMES M
Chief Financial Officer
32,500$31.89$1,036,459120,676
(Direct)
View
2023-01-06
Sale
2023-01-10
7:20 pm
Amylyx Pharmaceuticals Inc.AMLXFRATES JAMES M
Chief Financial Officer
2,658$36.3$96,48134,009
(Direct)
View
2021-06-16
Purchase
2021-06-17
4:04 pm
Sage Therapeutics Inc.SAGEFRATES JAMES M
Director
1,810$55.1$99,7352,845
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-08-23
Exercise(A)
2024-09-05
7:55 pm
N/A
N/A
Amylyx Pharmaceuticals Inc.AMLXFRATES JAMES M
Chief Financial Officer
18,165$6.88457,158
(Direct)
View
2023-08-23
Exercise(A)
2024-09-05
7:55 pm
N/A
2031-01-25
Amylyx Pharmaceuticals Inc.AMLXFRATES JAMES M
Chief Financial Officer
18,165$0457,158
(Direct)
View
2024-06-10
Option Award
2024-06-11
4:58 pm
N/A
2034-06-09
Sage Therapeutics Inc.SAGEFRATES JAMES M
Director
12,500$012,500
(Direct)
View
2024-04-16
Option Award
2024-04-18
8:23 pm
N/A
2034-04-15
Amylyx Pharmaceuticals Inc.AMLXFRATES JAMES M
Chief Financial Officer
211,180$0372,495
(Direct)
View
2024-02-26
Option Award
2024-02-28
6:44 pm
N/A
2034-02-25
Amylyx Pharmaceuticals Inc.AMLXFRATES JAMES M
Chief Financial Officer
100,000$0223,107
(Direct)
View
2024-01-03
Option Award
2024-01-04
4:07 pm
N/A
2034-01-03
Sage Therapeutics Inc.SAGEFRATES JAMES M
Director
4,925$04,925
(Direct)
View
2023-10-31
Gift
2023-11-02
3:33 pm
N/A
N/A
Amylyx Pharmaceuticals Inc.AMLXFRATES JAMES M
Chief Financial Officer
11,072$0125,823
(Indirect)
View
2023-08-23
Exercise
2023-08-24
4:15 pm
N/A
N/A
Amylyx Pharmaceuticals Inc.AMLXFRATES JAMES M
Chief Financial Officer
18,165$6.88489,658
(Direct)
View
2023-08-23
Exercise
2023-08-24
4:15 pm
N/A
2031-01-25
Amylyx Pharmaceuticals Inc.AMLXFRATES JAMES M
Chief Financial Officer
18,165$0489,658
(Direct)
View
2023-06-15
Option Award
2023-06-16
4:06 pm
N/A
2033-06-15
Sage Therapeutics Inc.SAGEFRATES JAMES M
Director
10,000$010,000
(Direct)
View
2023-05-16
Exercise
2023-05-18
8:54 pm
N/A
N/A
Amylyx Pharmaceuticals Inc.AMLXFRATES JAMES M
Chief Financial Officer
32,500$6.88457,158
(Direct)
View
2023-05-16
Exercise
2023-05-18
8:54 pm
N/A
2031-01-25
Amylyx Pharmaceuticals Inc.AMLXFRATES JAMES M
Chief Financial Officer
32,500$0457,158
(Direct)
View
2022-01-06
Conversion(A)
2023-04-26
7:34 pm
N/A
N/A
Amylyx Pharmaceuticals Inc.AMLXFRATES JAMES M
Chief Financial Officer
19,482$019,482
(Indirect)
View

Ownership(A)
2023-04-26
7:30 pm
N/A
N/A
Amylyx Pharmaceuticals Inc.AMLXFRATES JAMES M
Chief Financial Officer
0$019,482
(Indirect)
View
2023-03-16
Exercise(A)
2023-03-24
6:48 pm
N/A
N/A
Amylyx Pharmaceuticals Inc.AMLXFRATES JAMES M
Chief Financial Officer
32,500$6.88567,676
(Direct)
View
2023-03-16
Option Award(A)
2023-03-24
6:48 pm
N/A
2033-03-16
Amylyx Pharmaceuticals Inc.AMLXFRATES JAMES M
Chief Financial Officer
119,167$0567,676
(Direct)
View
2023-03-16
Exercise(A)
2023-03-24
6:48 pm
N/A
2031-01-25
Amylyx Pharmaceuticals Inc.AMLXFRATES JAMES M
Chief Financial Officer
32,500$0567,676
(Direct)
View
2023-03-16
Option Award
2023-03-20
8:18 pm
N/A
2033-03-16
Amylyx Pharmaceuticals Inc.AMLXFRATES JAMES M
Chief Financial Officer
119,167$0120,676
(Direct)
View
2022-12-30
Exercise
2023-01-04
9:33 pm
N/A
N/A
Amylyx Pharmaceuticals Inc.AMLXFRATES JAMES M
Chief Financial Officer
5,000$6.88483,667
(Direct)
View
2022-12-30
Exercise
2023-01-04
9:33 pm
N/A
2031-01-25
Amylyx Pharmaceuticals Inc.AMLXFRATES JAMES M
Chief Financial Officer
5,000$0483,667
(Direct)
View
2022-06-16
Option Award
2022-06-17
4:36 pm
N/A
2032-06-16
Sage Therapeutics Inc.SAGEFRATES JAMES M
Director
9,947$09,947
(Direct)
View
2022-02-11
Option Award
2022-03-28
4:30 pm
N/A
2032-02-11
Amylyx Pharmaceuticals Inc.AMLXFRATES JAMES M
Chief Financial Officer
25,000$025,000
(Direct)
View
2022-01-06
Option Award
2022-01-10
8:28 pm
N/A
2032-01-06
Amylyx Pharmaceuticals Inc.AMLXFRATES JAMES M
Chief Financial Officer
174,167$0174,167
(Direct)
View

Ownership
2022-01-06
5:21 pm
N/A
2031-01-25
Amylyx Pharmaceuticals Inc.AMLXFRATES JAMES M
Chief Financial Officer
0$0452,000
(Direct)
View
2021-06-10
Option Award
2021-06-11
4:11 pm
N/A
2031-06-10
Sage Therapeutics Inc.SAGEFRATES JAMES M
Director
10,000$010,000
(Direct)
View
2020-06-09
Option Award
2020-06-11
4:18 pm
N/A
2030-06-09
Sage Therapeutics Inc.SAGEFRATES JAMES M
Director
10,000$010,000
(Direct)
View
2020-05-14
Exercise
2020-05-14
4:58 pm
N/A
N/A
Alkermes plc.ALKSFRATES JAMES M
SVP, Alks Inc; CFO ALKS
21,983$11.74247,497
(Direct)
View
2020-05-14
Exercise
2020-05-14
4:58 pm
N/A
2020-05-17
Alkermes plc.ALKSFRATES JAMES M
SVP, Alks Inc; CFO ALKS
21,983$0247,497
(Direct)
View
2020-03-01
Exercise
2020-03-03
4:27 pm
2017-03-01
N/A
Alkermes plc.ALKSFRATES JAMES M
SVP, Alks Inc; CFO ALKS
4,500$0225,514
(Direct)
View
2020-03-01
Tax Withholding
2020-03-03
4:27 pm
N/A
N/A
Alkermes plc.ALKSFRATES JAMES M
SVP, Alks Inc; CFO ALKS
1,323$20.84225,514
(Direct)
View
2020-02-21
Tax Withholding
2020-02-24
4:11 pm
N/A
N/A
Alkermes plc.ALKSFRATES JAMES M
SVP, Alks Inc; CFO ALKS
1,712$20.24366,623
(Direct)
View
2020-02-20
Option Award
2020-02-24
4:11 pm
2021-02-20
2030-02-20
Alkermes plc.ALKSFRATES JAMES M
SVP, Alks Inc; CFO ALKS
126,811$0366,623
(Direct)
View
2020-02-21
Exercise
2020-02-24
4:11 pm
2020-02-21
N/A
Alkermes plc.ALKSFRATES JAMES M
SVP, Alks Inc; CFO ALKS
5,825$0366,623
(Direct)
View
2020-02-16
Tax Withholding
2020-02-18
4:07 pm
N/A
N/A
Alkermes plc.ALKSFRATES JAMES M
SVP, Alks Inc; CFO ALKS
2,076$17.77227,974
(Direct)
View
2020-02-16
Exercise
2020-02-18
4:07 pm
2019-02-16
N/A
Alkermes plc.ALKSFRATES JAMES M
SVP, Alks Inc; CFO ALKS
6,375$0227,974
(Direct)
View
2019-08-29
Ownership
2020-02-04
6:02 pm
N/A
N/A
Sage Therapeutics Inc.SAGEFRATES JAMES M
Director
1,500$01,035
(Direct)
View
(A) Indicate amendment filing.